证券日报网讯12月14日晚间，古鳌科技（300551）发布公告称，公司拟向徐迎辉发行不超4000万股A 股，发行后其拥有表决权的股份比例为32.36%，将触发要约收购义务；董事会提请股东会审议同意徐 迎辉可免于以要约收购方式增持公司股份。 ...

（编辑 王江浩） 证券日报网讯 12月14日晚间，古鳌科技发布公告称，2025年12月12日，公司第五届董事会第二十二次 会议审议通过《关于聘任公司副总经理、董事会秘书的议案》，同意聘任范宗辉先生为公司副总经理、 董事会秘书，任期自本次董事会审议通过之日起至第五届董事会任期届满之日止。 ...

Group 1 - The actual controller of Guao Technology will change to Xu Yinghui, a post-80s entrepreneur in the computing power industry, following the signing of a voting rights entrustment agreement with the previous controller, Chen Chongjun [2][3] - Xu Yinghui currently holds 4.50% of the company's shares directly, and with the voting rights entrusted to him, his total voting rights will amount to 24.41% [3] - Guao Technology plans to issue up to 40 million shares to Xu Yinghui at a price of 10.8 yuan per share, aiming to raise no more than 432 million yuan for working capital [3] Group 2 - Xu Yinghui's main holding company, Guanghui Shilian, has established computing power centers in 14 cities across China, focusing on key technology research in industrial computing [4] - Xu Yinghui has previously invested in the Sci-Tech Innovation Board company, Maixinlin, indicating his active role in the technology investment sector [4] - Guao Technology's main business includes financial equipment and derivatives, with a reported revenue of 298 million yuan in 2024, a year-on-year decrease of 47.60%, and a net loss of 351 million yuan [7]

Corporate Changes - Wang Ying, the chairman of Pudong Jinqiao, has resigned due to work transfer [2] - Xu Yinghui has become the new actual controller of Gu Ao Technology after a voting rights entrustment agreement [4][5] Profit Distribution - Xiangsheng Medical plans to distribute a cash dividend of 3 yuan per 10 shares for the first three quarters of 2025 [3] Investment Projects - Jiaze New Energy intends to invest approximately 3.557 billion yuan in a green hydrogen and methanol co-production project in Jixi City, Heilongjiang Province [6] - Longfei Optical Fiber's subsidiary plans to participate in establishing an investment fund with a total subscription amount of 830 million yuan [11] Financing Activities - Jinpan Technology has received approval from the China Securities Regulatory Commission to issue convertible bonds to unspecified investors [7] Acquisitions - Zoli Pharmaceutical has signed an agreement to acquire a multi-trace element injection asset group from Future Medicine for a total price of 356 million yuan [8] Product Approvals - Nine安 Medical's U.S. subsidiary has received pre-market notifications from the FDA for its multi-detection kits for various viruses [9] National Projects - Saiyi Information has been approved to lead a national major science and technology project focused on intelligent manufacturing systems and robotics [10]

Core Viewpoint - The change in actual control of Guoao Technology marks a new development phase for the company, providing impetus for business transformation and sustainable growth [1] Group 1: Control Change - The actual controller of Guoao Technology has changed from Chen Chongjun to Xu Yinghui, with the control transfer process completed [1] - Xu Yinghui has been granted voting rights for 67.6935 million shares, representing 19.91% of the total share capital, making him the actual controller with a total voting power of 24.41% after including his existing shares [2] - The voting rights agreement allows Xu to exercise all shareholder rights except for income and disposal rights, enabling him to influence board composition and company strategy [2] Group 2: Financing and Business Strategy - Guoao Technology plans to issue up to 40 million A-shares at a price of 10.80 yuan per share, aiming to raise up to 432 million yuan for working capital [3] - Following the issuance, Xu Yinghui's voting power could increase to 32.36%, further stabilizing control [3] - The new actual controller is expected to drive business transformation and explore new opportunities, leveraging the recent regulatory changes in the financial technology sector [3] Group 3: Market Context and Future Outlook - Guoao Technology has faced operational pressures due to industry changes and increased competition, with traditional business growth slowing [1] - The implementation of the "Financial Infrastructure Supervision and Management Measures" is seen as a potential opportunity for the company to adapt and grow [3] - The success of the company's future growth will depend on its ability to effectively transition its business model and find new growth points in the evolving market [4]

Group 1 - Pudong Jinqiao's chairman Wang Ying has resigned due to job transfer, ceasing to hold positions as director, chairman, and committee member [2] - Xiangsheng Medical plans to distribute a cash dividend of 3 yuan per 10 shares to all shareholders based on the total share capital [3] - Gu Ao Technology's actual controller has changed to Xu Yinghui, with stock resuming trading on December 15 [4] Group 2 - Jiaze New Energy plans to invest approximately 3.557 billion yuan in a green hydrogen and aviation fuel chemical co-production project in Jixi City [5] - Jinpan Technology has received approval from the China Securities Regulatory Commission to issue convertible bonds to unspecified investors [6] - Zoli Pharmaceutical intends to acquire a multi-trace element injection asset group for a total price of 356 million yuan [7] Group 3 - Jiuan Medical's U.S. subsidiary has received pre-market notifications from the FDA for four and three-in-one testing products [8] - Saiyi Information has been approved for a national major science and technology project focusing on intelligent manufacturing systems and robotics [9] - Changfei Fiber's subsidiary plans to participate in establishing an investment fund with a total subscription amount of 830 million yuan [10] Group 4 - Chengfeng Technology's shareholder, Hangzhou Hongwo, plans to reduce its stake by up to 3% of the company's shares [12] - Minxin Co., Ltd.'s deputy general manager plans to reduce holdings by up to 220,000 shares, representing 0.3925% of the total share capital [13] - Xinle Energy's director plans to reduce holdings by up to 400,000 shares, accounting for 0.07% of the total share capital [14]

古鳌科技（300551）(300551.SZ)披露2025年度向特定对象发行A股股票预案，公司拟向徐迎辉发行股票 不超过4000万股(含本数)，发行价格为10.80元/股。本次向特定对象发行股票募集资金金额不超过4.32亿 元(含本数)，扣除发行费用后，全部用于补充流动资金。 ...

智通财经APP讯，古鳌科技(300551.SZ)公告，公司实际控制人陈崇军与徐迎辉签署《表决权委托协 议》，协议约定陈崇军持有上市公司6769.35万股股份的表决权委托给徐迎辉，占公司总股本的 19.91%。截至本协议签署之日，徐迎辉直接持有上市公司股权比例为4.50%;《表决权委托协议》生效 后，徐迎辉通过表决权委托的方式新增持有上市公司的表决权比例为19.91%，徐迎辉合计持有上市公 司表决权比例为24.41%，上市公司实际控制人变更为徐迎辉。 ...

古鳌科技（300551）(300551.SZ)公告，公司实际控制人陈崇军与徐迎辉签署《表决权委托协议》，协 议约定陈崇军持有上市公司6769.35万股股份的表决权委托给徐迎辉，占公司总股本的19.91%。截至本 协议签署之日，徐迎辉直接持有上市公司股权比例为4.50%;《表决权委托协议》生效后，徐迎辉通过表 决权委托的方式新增持有上市公司的表决权比例为19.91%，徐迎辉合计持有上市公司表决权比例为 24.41%，上市公司实际控制人变更为徐迎辉。 ...

Core Viewpoint - The actual controller of Guao Technology has changed from Chen Chongjun to Xu Yinghui, and the company's stock will resume trading on December 15 [1] Group 1: Change of Control - On December 12, Chen Chongjun signed a voting rights entrustment agreement with Xu Yinghui, transferring the voting rights of 67.6935 million shares to Xu [1] - After the agreement takes effect, Xu Yinghui will hold 19.91% of the voting rights in the company, with a direct shareholding of 4.5%, resulting in a total voting rights percentage of 24.41% [1] Group 2: Fundraising Plan - Guao Technology announced a private placement plan, with the actual controller Xu Yinghui as the target for the stock issuance [1] - The total amount of funds to be raised from this issuance will not exceed 432 million yuan, subject to the approval of the regulatory authority [1] - The funds raised will be used entirely to supplement working capital after deducting related issuance costs [1]